Car & General (Kenya) Statistics

Total Valuation

NASE:CGEN has a market cap or net worth of KES 1.64 billion. The enterprise value is 9.39 billion.

Market Cap	1.64B
Enterprise Value	9.39B

Important Dates

The last earnings date was Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	May 30, 2025

Share Statistics

NASE:CGEN has 80.21 million shares outstanding.

Current Share Class	80.21M
Shares Outstanding	80.21M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.48%
Owned by Insiders (%)	11.15%
Owned by Institutions (%)	n/a
Float	10.33M

Valuation Ratios

The trailing PE ratio is 3.16.

PE Ratio	3.16
Forward PE	n/a
PS Ratio	0.08
PB Ratio	0.28
P/TBV Ratio	0.30
P/FCF Ratio	1.53
P/OCF Ratio	1.16
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 8.73.

EV / Earnings	18.11
EV / Sales	0.45
EV / EBITDA	8.02
EV / EBIT	11.54
EV / FCF	8.73

Financial Position

The company has a current ratio of 0.97, with a Debt / Equity ratio of 1.34.

Current Ratio	0.97
Quick Ratio	0.31
Debt / Equity	1.34
Debt / EBITDA	8.20
Debt / FCF	7.25
Interest Coverage	0.50

Financial Efficiency

Return on equity (ROE) is 9.11% and return on invested capital (ROIC) is 2.58%.

Return on Equity (ROE)	9.11%
Return on Assets (ROA)	1.85%
Return on Invested Capital (ROIC)	2.58%
Return on Capital Employed (ROCE)	7.26%
Revenue Per Employee	5.74M
Profits Per Employee	142,036
Employee Count	3,743
Asset Turnover	1.04
Inventory Turnover	2.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.98% in the last 52 weeks. The beta is -0.64, so NASE:CGEN's price volatility has been lower than the market average.

Beta (5Y)	-0.64
52-Week Price Change	-12.98%
50-Day Moving Average	22.76
200-Day Moving Average	23.17
Relative Strength Index (RSI)	43.27
Average Volume (20 Days)	1,750

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NASE:CGEN had revenue of KES 20.94 billion and earned 518.29 million in profits. Earnings per share was 6.46.

Revenue	20.94B
Gross Profit	3.21B
Operating Income	593.62M
Pretax Income	781.29M
Net Income	518.29M
EBITDA	801.89M
EBIT	593.62M
Earnings Per Share (EPS)	6.46

Full Income Statement

Balance Sheet

The company has 317.97 million in cash and 7.80 billion in debt, giving a net cash position of -7.48 billion or -93.26 per share.

Cash & Cash Equivalents	317.97M
Total Debt	7.80B
Net Cash	-7.48B
Net Cash Per Share	-93.26
Equity (Book Value)	5.81B
Book Value Per Share	69.17
Working Capital	-358.61M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.41 billion and capital expenditures -334.98 million, giving a free cash flow of 1.08 billion.

Operating Cash Flow	1.41B
Capital Expenditures	-334.98M
Free Cash Flow	1.08B
FCF Per Share	13.41

Full Cash Flow Statement

Margins

Gross margin is 15.33%, with operating and profit margins of 2.83% and 2.47%.

Gross Margin	15.33%
Operating Margin	2.83%
Pretax Margin	3.73%
Profit Margin	2.47%
EBITDA Margin	3.83%
EBIT Margin	2.83%
FCF Margin	5.13%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.91%.

Dividend Per Share	0.80
Dividend Yield	3.91%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	3.91%
Earnings Yield	31.60%
FCF Yield	65.56%

Dividend Details

Stock Splits

The last stock split was on March 25, 2022. It was a forward split with a ratio of 2.

Last Split Date	Mar 25, 2022
Split Type	Forward
Split Ratio	2

Scores

NASE:CGEN has an Altman Z-Score of 1.57. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.57
Piotroski F-Score	n/a